The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
910
November 26, 1993
View Complete Issue         Table of Contents 2019 
Rimantadine for Prevention and Treatment of Influenza
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Rimantadine for Prevention and Treatment of Influenza
November 26, 1993 (Issue: 910)
Rimantadine hydrochloride (Flumadine - Forest), the alpha-methyl derivative of amantadine (Symmetrel, and others), was recently approved by the US Food and Drug Administration for prevention and treatment of influenza A virus infections in adults...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Rimantadine for Prevention and Treatment of Influenza
Article code: 910b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.